Adrenal Cortical Carcinoma — Trials

Adrenal Cortical Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 16
Ph III recruiting: 0
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05361083	First-in-human Evaluation of [18F]CETO	completed	Early Phase 1	20	Uppsala UniversityOTHER	1	May 4, 2022	clinicaltrials
NCT00436410	Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer	completed	Early Phase 1	108	National Institutes of Health Clinical Center (CC)NIH	1	May 2, 2012	clinicaltrials